Abstract
A great part of the population appears to have insufficient folate intake, especially subgroups with higher demand, as determined through more sensitive methods and parameters currently in use. As the role of folate deficiency in congenital defects, e.g. in cardiovascular and neurodegenerative diseases, and in carcinogenesis has become better understood, folate has been recognized as having great potential to prevent these many disorders through folate supplementation or fortification for the general population. Folates are essential cofactors in the transfer and utilization of one-carbon groups in the process of DNA-biosynthesis with implications for genomic repair and stability. Folate acts indirectly to lower homocysteine levels and insures optimal functioning of the methylation cycle. Homocysteine was shown to be an independent risk factor for neurodegenerative and cardiovascular disease, which includes peripheral vascular disease, coronary artery disease, cerebrovascular disease and venous thrombosis. In fact, it was long believed that the beneficial effects of folate on vascular function and disease are related directly to the mechanism of homocysteine-diminution. Recent investigations have, however, demonstrated beneficial effects of folates unrelated to homocysteine-diminution, suggesting independent properties. One such mechanism could be free radical scavenging and antioxidant activity, as it is now recognized that free radicals play an important role in the oxidative stress leading to many diseases. It was found that folic acid and, in particular, its reduced derivates act both directly and indirectly to produce antioxidant effects. Folates interact with the endothelial enzyme NO synthase (eNOS) and, exert effects on the cofactor bioavailability of NO and thus, on peroxynitrite formation. Folate metabolism provides an interesting example of gene-environmental interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Ang:
-
angiotensin
- BH4:
-
tetrahydrobiopterin
- CAD:
-
coronary artery disease
- CβS:
-
cystathionine-β-synthase
- DDPH:
-
2,2-diphenyl-1-picrylhydrazyl
- DHF:
-
dihydrofolate
- DHFR:
-
dihydrofolate reductase
- ED:
-
endothelial dysfunction
- EDHF:
-
endothelium-derived hyperpolarizing factor
- EDRF:
-
endothelial derived relaxing factor
- eNOS:
-
Endothelial NO synthase
- FRAP:
-
ferric reducing ability of plasma
- GPx:
-
glutathione peroxidase
- Hcy:
-
homocysteine
- HHcy:
-
hyperhomocysteinemia
- H2O2 :
-
hydrogen peroxide
- LDL:
-
low density lipoprotein
- LPO:
-
lipid peroxidation
- MDA:
-
malondialdehyde
- MS:
-
methionine synthase
- MTHFR:
-
methylenetetrahydrofolate reductase
- 5-MTHF:
-
5-methyl-tetrahydrofolate
- NO:
-
nitric oxide
- O2 − :
-
superoxide anion
- ·OH:
-
hydroxyl radical
- ONOO− :
-
peroxynitrite
- PG:
-
prostaglandin
- RF:
-
relaxing factor
- RFC-1:
-
reduced folate carrier-1
- ROS:
-
radical oxygen species
- SAM:
-
S-adenosylmethionine
- SOD:
-
superoxide dismutase
- TAC:
-
total antioxidant capacity
- TAS:
-
total antioxidant status
- TBARS:
-
2-thiobarbituric acid-reactive substances
- TEAC:
-
trolox equivalent antioxidant capacity
- THF:
-
tetrahydrofolate
- TNFα:
-
tumor necrosis factor α
- TXB2:
-
thromboxane B2
References
Anguera MC, Suh JR et al. (2003) Methylenetetrahydrofolate synthetase regulates folate turnover and accumulation. J Biol Chem 278:29856–29862
Anthony AC (1996) Folate receptors. Annu Rev Nutr 16:501–521
Antoniades C, Shirodaria C, Leeson P, Baarholm OA, Van Assche T, Cunnington C, Pillai R, Ratnatunga C, Tousoulis D, Stefanadis C, Refsum H, Channon KM (2009) MTHFR 677C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119:2507–2515
Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, Channon KM (2006) 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels. Circulation 114:1193–1201
Austin RC, Sood SK, Dorward AM, Singh G, Shaughnessy SG, Pamidi S, Outinen PA, Weitz JI (1998) Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. J Biol Chem 273:30808–30817
Baggott JE, Tamura T, Baker H (2001) Re-evaluation of the metabolism of oral doses of racemic carbon isomers of formyltetrahydrofolate in human subjects. Br J Nutr 85:653–657
Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424–C1437
Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analyt Biochem 239:70–76
Blair JA (1957) Some observations on the oxidative degradation of pteroyl-L-glutamic acid. Biochem J 65:209–211
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 274:1049–1057
Bunout D, Petermann M, Hirsch S, de la Maza P, Suazo M, Barrera G, Kauffman R (2000) Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition 16:434–438
Campolo J, Chiara B, Caruso R, De Maria R, Sedda V, Dellanoce C, Parolini M, Cighetti G, Penco S, Baudo F, Parodi O (2006) Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia. Free Radic Res 40:929–935
Caruso R, Campolo J, Sedda V, De Chiara B, Dellanoce C, Baudo F, Tonini A, Parolini M, Cighetti G, Parodi O (2006) Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia. J Cardiovasc Pharmacol 47:549–555
Celano L, Gil M, Carballal S, Duran R, Denicola A, Banerjee R, Alvarez B (2009) Inactivation of cystathionine β-synthase with peroxynitrite. Arch Biochem Biophys Arch Biochem Biophys 491:96–105
Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22:854–858
Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99:1156–1160
Chang CM, Yu CC, Lu HT, Chou YF, Huang RF (2007) Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr 97:855–863
Chen N, Liu Y, Greiner CD, Holtzman JL (2000) Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 136:58–65
Chiao JH, Roy K, Tolner B, Yang CH, Sirotnak FM (1997) RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 272:11165–11170
Chippel D, Scrimgeour KG (1970) Oxidative degradation of dihydrofolate and tetrahydrofolate. Can J Biochem 48:999–1009
Coppola A, D’Angelo A, Fermo I, Mazzola G, Di Minno M, Cajani A, Sala A, Folco G, Tremoli E, Di Minno G (2005) Reduced in vivo oxidative stress follwoing 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. Br J Haematol 131:100–108
Crabtree MJ, Tatham AL, Hale AB, Alp NJ, Channon KM (2009) Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling. J Biol Chem 284:28128–28136
Darley-Usmar V, Wiseman H, Halliwell B (1995) Nitric oxide and oxygen radicals: A question of balance. FEBS Lett 369:131–135
Das U (2003) Folic acid says NO to vascular disease. Nutrition 19:686–692
Davi G, Di Minno G, Coppola A, Andria G, Cerbone AM, Madonna P, Tufano A, Falco A, Marchesani P, Ciabattoni G, Patrono C (2001) Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 104:1124–1128
Delfino VD, Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T (2007) Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 23:242–247
Donnelly JG (2001) Folic acid. Crit Rev Clin Lab Sci 38:183–221
Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105:22–26
Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95
Durand P, Lussier-Cacan S, Blache D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11:1157–1168
Faraci FM, Didion SP (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24:1367–1373
Ferrer-Sueta G, Radi R (2009) Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 4:161–177
Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak A, Leblhuber F (2001) Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med 39:691–694
Fukai T, Folz RJ, Landmesser U, Harrison DG (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55:239–249
Gao L, Chalupsky K, Stefani E, Cai H (2009) Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J Mol Cell Cardiol 47:752–760
Ghandour H, Chen Z, Selhub J, Rozen R (2004) Mice deficient in methylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates. J Nutr 134:2975–2978
Gliszczynska-Swiglo A (2007) Folates as antioxidants. Food Chem 101:1480–1483
Gliszcznska-Swiglo A, Muzolf M (2007) PH-dependent radical scavenging activity of folates. J Agric Food Chem 55:8237–8242
Haenen GR, Bast A (1983) Protection against lipid peroxidation by a microsomal glutathione-dependent labile factor. FEBS Lett 159:24–28
Handy DE, Zhang Y, Loscalzo J (2005) Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 280:15518–15525
Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96:3390–3395
Heales SJ, Blair JA, Meinschad C, Ziegler I (1988) Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin, and the free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin. Cell Biochem Funct 6:191–195
Heinecke JW, Kawamura M, Suzuki, L, Chait A (1993) Oxidation of low-density lipoprotein by thiols: superoxide-dependent and –independent mechanisms. J Lipid Res 34:2051–2061
Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER (2001) L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276:40–47
Higashi-Okai K, Nagino H, Yamada K, Okai Y (2007) Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation. J UOEH 28:359–368
Hirsch S, Ronco AM, Vasquez M, de la Maza MP, Garrido A, Barrera G, Gattas V, Glasinovic A, Leiva L, Bunout D (2004) Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. Nutrition 134:1832–1835
Huang A, Vita JA, Venema RC, Keaney JF (2000) Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275:17399–17406
Huang RF, Hsu YC, Lin HL, Yang FL (2001) Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 131:33–38
Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG (2002) Interactions of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282:2167–2172
Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T (2001) Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Rad Biol Med 30:1390–1399
Kathy KW, Au-Yeung KW, Woo CW, Sung FL, Yip JC, Siow YL, OK (2004) Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res 94:28–36
Kuzkaya N, Weissmann N, Harrison DG, Dikalov S (2003) Interaction of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278:22546–22554
Lindschinger M, Nadlinger K, Adelwöhrer N, Holweg K, Wögerbauer M, Birkmayer J, Smolle KH, Wonisch W (2004) Oxidative stress: potential of distinct peroxide determination systems. Clin Chem Lab Med 42:907–914
Loscalzo J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98:5–7
Luhrs CA, Slomiany BL (1989) A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J Biol Chem 264:21446–21449
Lulock MD, Proestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI (1995) Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailibility. Biochem Mol Med 55:43–53
Mayer B, Schumacher M, Brandstätter H, Wagner FS, Hermetter A (2001) High-throughput fluorescence screening of antioxidative capacity in human serum. Anal Biochem 297:144–153
Mayer O, Simon J, Rosolova H, Hromadka M, Subrt I, Vobrubova I (2002) The effects of folate supplementation on some coagulation parameters and oxidative status surrogates. Eur J Clin Pharmacol 58:1–5
McCaddon A, Regland B, Hudson P, Davies G (2002) Functional vitamin (B)12 deficiency and Alzheimer disease. Neurology 58:1395–1939
McCarthy MF, Barroso-Aranda J, Contreras F (2009) High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals. Clinical potential in inflammatory disorders. Med Hypothesis 73:824–834
McEneny J, Couston C, McKibben B, Young IS, Woodside JV (2007) Folate: in vitro and in vivo effects on VLDL and LDL oxidation. Int J Vitam Nutr Res 77:66–72
Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD (2003) Role of hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92: e31–e40
Moens AL, Claeys M, Wuytis FL et al. (2004) Folic acid reduces myocardial ischemia and reperfusion injury by influencing the NO pathway: an in vitro and in vivo study. Circulation 110:III–50
Mosharov E, Cranford MR, Banerjee R (2000) The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the trassulfuration pathway and its regulation by redox changes. Biochemistry. 39:13005–13011
Mudd SH, Skovby F, Levy HL, Pettigrew KR, Wilcken B, Pyeritz R, Andria G, Boers GH, Bromberg IL, Cerone R et al. (1985) The natural history of homocystinuria due to cystathionine-β-synthase deficiency. Am J Hum Genet 37:1–31
Murr C, Baier-Bitterlich G, Fuchs D, Werner ER, Esterbauer H, Pfleiderer W, Wachter H (1996) Effects of neopterin-derivatives on H2O2-induced luminol chemiluminescence: mechanistic aspects. Free Radic Biol Med 21:449–456
Nakamura M, Nagayoshi R, Ijiri K, Nakashima-Matsushita N, Takeuchi T, Matsuyama T (2002) Nitration and chlorination of folic acid by peroxynitrite and hypochlorous acid, and the selective binding of 10-nitro-folate to folate receptor beta. Biochem Biophys Res Comm 297:1238–1244
Odin E, Carlsson G, Frosing R, Gustavsson B, Spears CP, Larsson PA (1998) Chemical stability and human plasma pharmacokinetics of reduced folates. Cancer Invest 447–455
Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL et al. (1994) Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59:940–948
Patro BS, Adhikari S, Mukherjee T, Chattopadhyay S (2005) Possible role of hydroxyl radicals in the oxidative degradation of folic acid. Bioorg Med Chem Lett 15:67–71
Patrono C, Fitzgerald GA (1997) Isoprsotanes: potential markers of oxidant stress in atherothrombotic diseae. Arterioscler Thromb Vasc Biol 17:2309–2315
Prasad PD, Ramamoorthy S, Moe AJ, Smith CH, Leibach FH, Ganapathy V (1994) Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta 1223:71–75
Pullin CH, Bonham JR, McDowell IF, Lee PJ, Powers HJ, Wilson JF, Lewis MJ, Moat SJ (2002) Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria. J Inherit Metab Dis 25:107–118
Rice-Evans CA, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279–293
Rimm EB, Willett WC, Hu FB et al (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 279:359–364
Rogers EJ, Chen SS, Chan A (2007) Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med 357:421–422
Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L et al. (1998) Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group. Circulation 97:437–443
Rzek BM, Haenen GR, van der Vijgh WJ, Bast A (2003) Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore. FEBS Lett 555:601–605
Said HM, Nguyen TT, Dyer DL, Cowan KH, Rubin SA (1996) Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochim Biophys Acta 1281:164–172
Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906
Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, Longstreth WT, Koepsell TD, Raghunathan TE et al. (1997) Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96:412–417
Scott JM, Weir DG (1981) The methyl folate trap. Lancet 8242:838–840
Shane B (1989) Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45:263–335
Shaw S, Jayatilleke E, Herbert V, Colman N (1989) Cleavage of folates during ethanol metabolism. Biochem J 257:277–280
Shidfar F, Homayounfar R, Fereshtehnejad SM, Kalani A (2009) Effect of folate supplementation on serum homocysteine and plasma antioxidant capacity in hyüercholesterolemic adults under lovastatin treatment: a double-blind randomized controlles clinical trial. Arch Med Red 40:380–386
Sies H, Sharov VS, Klotz LO, Briviba K (1997) Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272:27812–27817
Sirotnak FM, Tolner B (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19: 91–122
Spijkerman AM, Smulders YM, Kostense PJ, Henry RM, Becker A, Teerlink T, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD (2005) S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study. Arterioscler Thromb Vasc Biol 25:778–784
Sprecher E, Bergman R, Sprecher H, Maor G, Reiter I, Krivoy N, Drori S, Assaraf YG, Friedman-Birnbaum R (1998) Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin. Arch Dermatol Res 290:656–660
Stanger O (2002) Physiology of folic acid in health and disease. Curr Drug Metab 3:211–223
Stanger O, Fowler B, Pietrzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M (2009) Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother 9:1393–1412
Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2003) consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403
Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC (2002) Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303:158–162
Stanger O, Weger M (2003) Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 41:1444–1454
Stanger O, Weger M, Renner W, Konetschny R (2001) Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease. Clin Chem Lab Med 39:725–733
Steinberg SE, Campbell CL, Hillmann RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64:83–88
Stocker P, Lesgards JF, Vidal N, Chalier F, Prost M (2003) ESR study of a biological assay on whole blood: antioxidant efficiency of various vitamins. Biochim Biophys Acta 1621:1–8
Stralin P, Karlsson K, Johansson BO, Marklund SL (1996) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15:2031–2036
Stroes ES, van Faassen EE, Yo M, Martasek P, Govers R, Rabelink TJ (2000) Folic acid recerts dysfunction of endothelial nitric oxide synthase. Circ Res 86:1129–1134
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954
Tatzber F, Griebenow S, Wonisch W, Winkler R (2002) Dual method for the determination of peroxidase activity and total peroxides – iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 316:147–153
Tchantchou F (2006) Homocysteine increase folate oxidative brain homocysteine metabolism and various consequences of folate deficiency. J Alzheimers Dis 421–427
Ungvari Z, Csiszar A, Bagi Z, Koller A (2002) Impaired NO-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 161:145–153
Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, Koller A (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia. Role of tumor necrosis factor-α, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23:418–424
Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Loscalzo J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012–17017
Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T (1999) Endothelial dysfunction by acute hyperhomocyst(e)inemia: restoration by folic acid. Clin Sci 96:235–239
Verhaar MC, Stroes E, Rabelink TJ (2002) Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22:6–13
Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ (1998) 5-methyltetrahyrofolate, the active form of folic acid, improves endothelial dysfunction in familial hypercholesterolemia. Circulation 97:237–241
Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143:845–859
Verlinde PH, Oey I, Hendrickx ME, van Loey AM, Temme EH (2008) L-ascorbic acid improves the serum folate response to an oraal dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr 62:1224–1230
Voutilainen S, Morrow JD, Roberts LJ, Alfthan G, Alho H, Nyyssönen K, Salonen JT (1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19:1263–1266
Weiss N, Heydrick S, Zhang YY, Bierl C, Loscalzo J (2002) Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22:34–41
Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J (2001) Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci USA 98:12503–12508
Widner B, Enzinger C, Laich A, Wirleitner B, Fuchs D (2002) Hyperhomocysteinemia, pteridines and oxidative stress. Curr Drug Metab 3:225–232
Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B (2001) Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? J Neurol Neurosurg Psychiatr 70:419
Wilcken DE, Wang XL, Adachi T, Hara H, Duarte N, Gren K, Wilcken B (2000) Relationship between homocysteine and superoxide dismutase in homocystinuria. Possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol 20:1199–1202
Wilcken DE, Wilcken B (1997) The natural history of vascular disease in homocystinuria and effects of treatment. J Inherit Metab Dis 20:295–300
Wilmink HW, Stroes ES, Erkelens WD, Gerritsen WB, Wever R, Banga JD, Rabelink JD (2000) Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 20:185–188
Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH (2007) Proteasome-dependent degradation of guanosine 5′- triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116:944–953
Yamamoto M, Hara H, Adachi T (2000) Effect of homocysteine on the binding of extracellular-superoxide dismutase on the endothelial cell surface. FEBS Lett 486:159–162
Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER (2001) Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol 21:2080–2085
Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH (2000) Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost 26:335–340
Zeiher AM, Krause T, Schachinger V, Minners J, Moser E (1995) Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise induced myocardial ischemia. Circulation 91:2345–2352
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Stanger, O., Wonisch, W. (2012). Enzymatic and Non-enzymatic Antioxidative Effects of Folic Acid and Its Reduced Derivates. In: Stanger, O. (eds) Water Soluble Vitamins. Subcellular Biochemistry, vol 56. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2199-9_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-2199-9_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2198-2
Online ISBN: 978-94-007-2199-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)